Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
$18.5bn IPL valuation draws KKR, Blackstone and CVC into India’s sports gold rush
$18.5bn IPL valuation draws KKR, Blackstone and CVC into India’s sports gold rush India’s Indian Premier League has emerged as a serious private equity target, with global firms including KKR, Blackstone, Partners Group, and CVC Capital circling franchise stakes as...
Carlyle readies €4bn debt sale to back €7.7bn BASF Coatings carve-out
Carlyle readies €4bn debt sale to back €7.7bn BASF Coatings carve-out Carlyle is moving closer to the next phase of its €7.7bn acquisition of BASF SE’s coatings business, as banks prepare to syndicate around €4bn of debt to finance the buyout, Bloomberg reported. Bank...
CVC and M&G strike $1.1bn secondary deal to scale North American buyout exposure
CVC and M&G strike $1.1bn secondary deal to scale North American buyout exposure M&G Investments has deepened its push into private equity secondaries through a $1.1bn managed fund transaction with CVC Secondary Partners. Under the strategic partnership, funds...